Please input keywords
Biocytogen Boston Corp.
RenMice™ HiTS Platform
Antibody discovery platforms
Antibody drug R&D
Unlocking competitive edge through integrated innovation
Bispecific Antibody Platform
RenLite common light-chain mouse platform, bispecific antibody assembly platform, and streamlined discovery process
Bispecific ADC Platform
Streamlined RenLite-based bsADC discovery process for 200+ TAA
TCR-Mimic Antibody Platform
TCRm antibodies for intracellular targets
GPCR Technology Platform
GPCR antibody discovery and screening supported by target knockout RenMice and target humanized mice.
Fully human antibody discovery...
Leveraging our proprietary fully human antibody mice, including RenMice (RenMab, RenLite, and RenNan...
Preclinical Pharmacology Evalu...
We design robust in vivo and in vitro study models to evaluate the efficacy and safety of candidate...
Large Animal Translational Res...
In comparison to implanted mouse tumor models, spontaneous tumors in larger animals, especially cani...
The Eucure clinical development team is highly experienced in drug development both domestically and...
Copyright © 2022 Biocytogen. All Rights Reserved
Powered by Fractal-technology